Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
5:1303-1307
InChiKey: CMSMOCZEIVJLDB-UHFFFAOYSA-N
CN(C)C(=O)OC1C=CC=[N+](C)C=1
Formula: C22H26FN5O6
SU14813 maleate - CAS# 849643-15-8 Size:Solid 10 mg 5:1303-1307SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet derived growth factor receptors (PDGFR), KIT, and fms like tyrosine kinase 3 (FLT 3) (1). SU14813 was developed as a next generation TKI agent following sunitinib (SU11248) designed to demonstrate optimized pharmacokinetic (PK) and tolerability profiles. SU14813 demonstrated broad and potent antitumor activity
US$ 1292.09
US$ 1508.50
US$ 752.00
US$ 38.89
US$ 49.99
US$ 392.50
US$ 26.89
US$ 188.40
US$ 22.89
US$ 343.09
US$ 22.89
US$ 160.80
US$ 92.40
US$ 121.80